StockData
Jupiter Neurosciences, Inc. logo

Jupiter Neurosciences, Inc. (JUNS) stock

JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$1.70−0.06 (-3.41%)

Close on Nov 16, 2026Market cap $1.31MP/E –Yield –

Jupiter Neurosciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Jupiter Neurosciences

Jupiter Neurosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Jupiter Neurosciences figures

See a number that looks wrong?